Avalon Investment & Advisory’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-67,899
| Closed | -$3.42M | – | 352 |
|
|
2018
Q3 | $3.42M | Buy |
67,899
+4,824
| +8% | +$243K | 0.1% | 191 |
|
|
2018
Q2 | $3.78M | Buy |
63,075
+25,786
| +69% | +$1.54M | 0.11% | 167 |
|
|
2018
Q1 | $1.71M | Buy |
37,289
+3,525
| +10% | +$161K | 0.05% | 224 |
|
|
2017
Q4 | $1.35M | Buy |
33,764
+1,132
| +3% | +$45.1K | 0.04% | 233 |
|
|
2017
Q3 | $1.31M | Sell |
32,632
-247
| -0.8% | -$9.88K | 0.04% | 223 |
|
|
2017
Q2 | $1.42M | Buy |
32,879
+4,114
| +14% | +$177K | 0.05% | 217 |
|
|
2017
Q1 | $900K | Buy |
+28,765
| New | +$900K | 0.03% | 258 |
|